| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-06 |
| filingDate |
2004-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2009-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99fa68080f037b5bfec43d741ced70b6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_785aa49c916c6ed71b49d57c36f4d367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63cbfbae981db9a83d4e0e0f7e15a7cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_234ae75edcdfed55b2c7c2e4857bd88c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_69d5b7543d53e67c6f537941002ba0c6 |
| publicationDate |
2009-02-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7494983-B2 |
| titleOfInvention |
Ophthalmic compositions for treating ocular hypertension |
| abstract |
This invention relates to potent potassium channel blocker compounds of structural Formula I or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also relates to the use of such compounds to provide a neuroprotective effect to the eye of mammalian species, particularly humans. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010298335-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8299079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8455494-B2 |
| priorityDate |
2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |